Summary of HB 584 (2026 Session, Kentucky)
Purpose
- HB 584 seeks to establish and enhance oversight of licensees authorized to prescribe or dispense controlled substances in Kentucky. It aims to standardize prescribing/dispensing practices, impose stricter reporting and disciplinary procedures, improve information sharing among agencies, and strengthen licensure and surveillance mechanisms to deter improper activities related to controlled substances.
Key Provisions and Changes
1) Expanded Reporting and Communication Among Agencies
- Reporting agencies (Department of Kentucky State Police, Office of the Attorney General, Cabinet for Health and Family Services, and applicable state licensing boards) can, within three business days, share reports of improper, inappropriate, or illegal prescribing or dispensing of controlled substances with other reporting agencies.
- County or Commonwealth's Attorneys must notify the Attorney General’s Office and the relevant state licensing board within three business days of an indictment or public waiver of indictment charging a licensed person with a felony related to manufacturing, trafficking, prescribing, dispensing, or possession of controlled substances.
2) Administrative Regulation Standards
- State licensing boards, in consultation with the Kentucky Office of Drug Control Policy, must establish by administrative regulation:
- Mandatory prescribing/dispensing standards for controlled substances, covering diagnostic, treatment, and review protocols for Schedule II substances and certain hydrocodone-containing Schedule III substances. May include exemptions under existing law.
- Prohibition on Schedule II prescriptions for more than a three-day supply when used to treat acute pain, with a detailed list of exceptions (e.g., medical necessity documented, chronic pain treatment, cancer-related pain, hospice/end-of-life care, narcotic treatment programs, surgery/trauma, inpatient dispensing, and other board-approved scenarios). The rule cannot expand practice authority beyond pre-June 29, 2017.
- Prohibition on dispensing more than a 48-hour supply of Schedule II or hydrocodone-containing Schedule III substances except within narcotic treatment programs.
- Procedures for temporary license suspensions/limitations when continued practice poses danger to patients or the public.
- Expedited complaint review process: investigation within 7 days of filing and charging decision within 120 days, subject to extensions for ongoing investigations by law enforcement.
- Licensure standards: potential permanent or temporary restrictions or bans based on felony or misdemeanor offenses related to controlled substances, mirroring disciplinary actions from other states, and reporting requirements for such actions.
- Reporting to the National Practitioner Data Bank (NPDB) for all disciplinary and reportable information.
- Optional NPDB queries for applicants to retrieve relevant data on licensing applicants.
- Continuing education: at least 7.5% of required CE must relate to electronic monitoring systems, pain management, or addiction disorders, starting with the first full year after July 1, 2012.
3) Medical Necessity Presumption
- For pharmacy dispensing, the medical necessity of a Schedule II substance and a prescription for more than a 3-day supply are presumed valid when properly documented by the practitioner.
4) Expert Evaluation
- Boards may hire or consult pain treatment and drug addiction specialists to evaluate prescribing/dispensing information if board staff lack expertise.
5) Complaint Integrity and Anonymity
- Grievances/complaints about controlled-substance prescribing or dispensing need not be sworn/notarized, unless required by regulation. Anonymous complaints may be allowed if accompanied by corroborating evidence.
6) Cooperation with Law Enforcement and Data Sharing
- Boards must cooperate with state, local, and federal law enforcement and other regulatory bodies to deter improper prescribing/dispensing.
- Mandatory fingerprints for initial licensure applicants: criminal record checks by the Kentucky State Police and FBI.
7) Definitions and Scope
- “Reporting agency” and “State licensing board” definitions include all relevant state police, attorney general, health cabinet, and professional licensing boards authorized to regulate prescribers/dispensers of controlled substances.
Affected Parties
- Licensees authorized to prescribe or dispense controlled substances (e.g., physicians, nurses, dentists, optometrists, podiatrists, and other relevant boards).
- State licensing boards (e.g., Kentucky Board of Medical Licensure, Board of Nursing, Board of Dentistry, Board of Optometric Examiners, Board of Podiatry, and others).
- Law enforcement agencies, the Office of the Attorney General, and the Cabinet for Health and Family Services.
- Applicants for licensure and practitioners undergoing discipline or investigation.
- Entities contributing to or utilizing the NPDB and electronic monitoring/pain management education programs.
Procedural and Timeline Aspects
- Reporting transfers: within 3 business days between reporting agencies; 3 business days for indictments/waivers reporting to AG and boards.
- Expedited complaint process: investigations within 7 days; charging decision within 120 days, with possible extensions for ongoing investigations.
- Education and training: CE requirements begin after the first full educational year post-July 1, 2012; 7.5% of CE related to monitoring, pain, or addiction topics.
- Implementation: Boards will promulgate regulations under KRS Chapter 13A to implement these standards, with ongoing cooperation and reporting requirements.
Overall Impact
- Strengthens oversight and discipline of prescribers/dispensers of controlled substances.
- Increases interagency information sharing and diagnostics-based standards.
- Expands use of data banks and background checks in licensure decisions.
- Narrows non-medically justified prescribing, particularly for Schedule II opioids in acute pain scenarios.
- Elevates continuing education focusing on pain management, addiction, and monitoring systems.
